Description
La Chloris Re-Creation Serum
is a concentrated anti-aging serum that uses lilac stem cells, vitamin C, and marine extracts, in order to to dramatically improve deep lines, texture, and brighten your skin.
Benefits:
– Lessens appearance of lines and wrinkles;
– Shields from environmental toxins, and free radical damage
– Lessens Progerin (the skin aging protein)
– Plumps skin appearance, through the use of hyaluronic acid
– Lessens blackheads, breakouts, and improves pore appearance
– Brightens skin and evens skin tone
– Helps to calm redness and rosacea
Featured Ingredients:
Vitamin C (Tetrahexyldecyl ascorbate):
Present at 3%, this antioxidant, skin brightening collagen-booster is 8 times stronger than L-ascorbic acid at collagen formation; it helps reverse sun damage by shielding from UVA as well as UVB.
Lilac Stem Cells:
Reactivates youthful genes, lessen inflammation and breakouts. Additionally, improves pore appearance, decreases pigmentation by tyrosinase inhibition, and fights free radicals damage.
Marine Algae Extract:
A Gene modulator found in marine extracts that has been shown to decrease Progerin, the skin’s aging protein.
Undaria Algae Extract:
Reactivates 14 genes that become deactivated over time and with aging. These genes are responsible for the production of collagen, elastin, and hyaluronic acid, the natural skin fillers and firming components. Reactivating these 14 genes helps to reduce wrinkles and helps to create a more youthful, lifted appearance.
How to Use:
After cleansing, apply to face and neck twice daily. Follow with a moisturizer or our Re-Creation Cream for maximum results.
Want to know more?
You can also mix our Re-Creation Serum with our Re-Creation Cream and maximize your results. Also for a full face care routine don’t forget you cleansers and SPF to protect yourself from UV damage. Check out these great products to complete your routine: Gentle Gel Cleanser, Exfoliating Gel Cleanser, Daily SPF 30 and Daily SPF 36 and see what is right for you.
Reviews
There are no reviews yet.